CKAP2L promotes endometrial cancer progression by suppressing AKT ubiquitination and activating the PI3K/AKT signaling pathway - Poll - MDSpire

CKAP2L promotes endometrial cancer progression by suppressing AKT ubiquitination and activating the PI3K/AKT signaling pathway

  • By

  • Min Wei

  • Xuefei Bai

  • Lili Xi

  • Yongxiu Yang

  • May 20, 2026

  • 0 min

Share

Original Source(s)

CKAP2L promotes endometrial cancer progression by suppressing AKT ubiquitination and activating the PI3K/AKT signaling pathway

  • by Min Wei, Xuefei Bai, Lili Xi, Yongxiu Yang

  • May 20, 2026

Related Content

Case Report: Synovial sarcoma with diffuse myxoid stroma and complete absence of epithelial differentiation in the extremity

Myelodysplastic syndromes complicated by atypical Sweet syndrome: a brief research report

Is full adherence mandatory? Real-world outcomes of completing perioperative chemoimmunotherapy in resectable non-small cell lung cancer